- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02697903
Pomegranate Improve Biological Recovery Kinetics in Elite Weightlifter
March 2, 2016 updated by: Ammar Achraf, The Higher Institute of Sport and Physical Education of Sfax
Pomegranate Supplementation Accelerates the Recovery Kinetics of Muscle Damage, Muscle Soreness and Inflammatory Marker After Weightlifting Training Session.
From the recent scientific literature in the field of biological response to physical exercise, a significant increase in muscle damage, soreness and inflammation were registered immediately and even 48 after resistance exercise.
In the other hand, from the recent scientific literature in the field of nutrition it is well established that Pomegranate juice is a potent antioxidant that can help prevent or treat various disease risk factors.
However, only few studies associated the effect of the pomegranate with the physical exercise.
To the authors' knowledge, there are no studies investigated the acute and delayed effect of pomegranate supplementation in performance and muscle recovery after exercises involved muscle of whole body.
Therefore, the aim of the present study was to investigate the effect of natural Pomegranate juice supplementation on the acute and delayed response of muscle soreness and biochemical parameters following weightlifting training session
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants (i.e., 9 elite weightlifters) performed-as part of their habitual training program from 08h:00 to 09h:45- two training sessions using respectively, PLA and POMj supplementations (500ml), with a recovery period of 48 h in between.
Upon arrival for their first test session, each participant's body mass and height were recorded.
Moreover, before and after each tested training session, oral temperature was recorded with a calibrated digital clinical thermometer (Omron, Paris, France; accuracy: 0.05°C) inserted sublingually for at least 3 min with the subjects in a seated resting position for at least 15 min.
Also, before and after each training session, fasting blood samples (blood sample 2, 3, 4 and 5, Figure1) were collected and heart rate (HR) and systolic arterial pressure (SAP) were recorded using a heart rate monitor and a manual sphygmomanometer.
Additionally, to assess the recovery kinetic of the biological parameters, blood sample, temperature, HR and SAP were collected at resting state (i.e., after 10 days of recovery, blood sample 6) and immediately (3min) after the training session which proceed the PLA session (blood sample 1).
Given that values of markers of muscle damage remain raised for at least 7 days following intensive weightlifting exercises, a recovery period of 10 days was chosen to evaluate the biological resting state.
Additionally, given that (i) using randomized order in this study will results in consuming POMj then PLA supplementations (after 48h) for some participant and (ii) the delayed effect of POMj (which we expect) could alter the results of PLA supplementation, in the present study investigators choose to avoid randomized order and to evaluate the PLA at first then the POMj effect using all the participant together.
Supplements (1500ml) of placebo (PLA) or pomegrenate juice (POMj) were taken three times daily in the 48h which proceed the first and the second tested training sessions respectively (i.e.
250ml × 6 times with 8-h intervals between it).
Moreover, during these tested sessions, subject consumed an additional 500ml of PLA and 500ml of POMj, respectively.
The tested quantity of the natural POMj were prepared from a fresh pomegranate fruit 48h before the beginning of the experimentation and were shipped frozen and stored at -4°C.
No additional chemical products were added to the natural POMj.
Each 500-mL of the tested POMj contained 2.56g of total polyphenol, 1.08g of ortho-diphenols, 292.59mg of flavonoids and 46.75mg of flavonols.
Subjects were reminded verbally through phone communication to consume at the required times their supplements.
Placebo juice consisted of an Pomegranate-flavored commercial drink contained water, citric acid, natural flavor and natural identical flavor (Pomegranate), sweeteners (aspartame × (0.3g/l), acesulfame K (0.16g/l)), stabilizers (Arabic gum) and lacked antioxidants, fruit and vegetable extracts or vitamins.
Placebo juice contains no polyphenols.
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sfax, Tunisia, 3000
- Achraf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 24 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- trained at least five sessions per week with 90 to 120 min per session
- had an experience of more than 3 years in Olympic weightlifting
Exclusion Criteria:
- use any antioxidant (e.g., vitamin E, A, C etc..) or anti-inflammatory during the experimentation period and one month before
- had injuries during the experimentation period and one month before
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 9 elite weightlifters
age: 21 ± 0.5 years, body mass: 80 ± 20 kg, height 175 ± 8.1 cm (mean ± SD).
They received "Natural Pomegranate Juice" supplementation during and 48h following the first weightlifting training session.
|
Supplements (1500ml) of pomegrenate juice (POMj) were taken three times daily in the 48h which proceed the first tested training sessions (i.e.
250ml × 6 times with 8-h intervals between it).
Moreover, during this tested sessions, subject consumed an additional 500ml of POMj.
Arm-specific: Experimental: 9 elite weightlifter
|
Placebo Comparator: 9elite weightlifters
age: 21 ± 0.5 years, body mass: 80 ± 20 kg, height 175 ± 8.1 cm (mean ± SD).
They received "Placebo Juice" supplementation during and 48h following the second weightlifting training session.
|
Supplements (1500ml) of Placebo juice (PLA) were taken three times daily in the 48h which proceed the second tested training sessions (i.e.
250ml × 6 times with 8-h intervals between it).
Moreover, during this tested sessions, subject consumed an additional 500ml of POMj.
Arm-specific: Placebo Comparator: 9 elite weightlifter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical performance from using Placebo to using Pomegranate juice
Time Frame: 3min after Placebo and Pomegranate training sessions
|
The performance in each session was measured by the total volume lifted in the two Olympic movements (volume lifted (kg) in snatch added volume lifted (kg) in clean and Jerk: only the right lifts are taken into consideration) and by the maximal power lifted amounts in both Olympic movement (i.e., the maximal load lifted (kg) in the power snatch added to the maximal load lifted (kg) in the power clean and Jerk)
|
3min after Placebo and Pomegranate training sessions
|
Change in Acute Hematological responses from using Placebo to using Pomegranate juice
Time Frame: 3min after Placebo and Pomegranate training sessions
|
Haematological parameters (i.e., white blood cells (WBC), neutrophils (NEU), red blood cells (RBC), hemoglobin (HGB), hematocrit (HCT)and platelets (PLT) were generally performed within 3 h of blood sampling in a multichannel automated blood cell analyser Beckman Coulter Gen system-2 (Coulter T540)
|
3min after Placebo and Pomegranate training sessions
|
Change in Acute Biochemical responses from using Placebo to using Pomegranate juice
Time Frame: 3min after Placebo and Pomegranate training sessions
|
Glycemia (GLY), Creatinine (CRE), muscle damage markers (Creatinine kinase (CK), Alkaline phosphate (PAL), Gammaglutamyl (GGT), Lactate dehydrogenase (LDH)) and c-reactive protein (CRP) were determined spectrophotometrically using Abott Architect Ci 4100
|
3min after Placebo and Pomegranate training sessions
|
Change in Delayed Hematological responses from using Placebo to using Pomegranate juice
Time Frame: 48h after Placebo and Pomegranate training sessions
|
Haematological parameters (i.e., white blood cells (WBC), neutrophils (NEU), red blood cells (RBC), hemoglobin (HGB), hematocrit (HCT)and platelets (PLT) were generally performed within 3 h of blood sampling in a multichannel automated blood cell analyser Beckman Coulter Gen system-2 (Coulter T540)
|
48h after Placebo and Pomegranate training sessions
|
Change in Delayed Biochemical responses from using Placebo to using Pomegranate juice
Time Frame: 48h after Placebo and Pomegranate training sessions
|
Glycemia (GLY), Creatinine (CRE), muscle damage markers (Creatinine kinase (CK), Alkaline phosphate (PAL), Gammaglutamyl (GGT), Lactate dehydrogenase (LDH)) and c-reactive protein (CRP) were determined spectrophotometrically using Abott Architect Ci 4100
|
48h after Placebo and Pomegranate training sessions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the acute fatigue perception (RPE values) from Placebo to Pomegranate supplementation
Time Frame: 3min after Placebo and Pomegranate training sessions
|
The RPE scale (15-points) runs from 6 (very, very light) to 20 (very, very hard) 10.
RPE scale measures feelings of effort, strain, discomfort, and/or fatigue experienced during physical task.
Although this is a subjective measure (person's exertion), RPE values were shown to provide good estimation of the increase in heart rate, muscle fatigue and several other physiological measures during physical activity
|
3min after Placebo and Pomegranate training sessions
|
Change in the delayed muscle soreness (DOMS values) from Placebo to Pomegranate supplementation
Time Frame: 48 after Placebo and Pomegranate training sessions
|
Delayed onset soreness (DOMS) of the knee extensor and elbow flexor was determined 48 hours after training sessions.
48h after each training session, participants were asked to rate subjectively the degree of soreness in both muscles using a visual analog scale of 0 (absence of soreness) to 10 (unbearable soreness) [28].
Soreness was normalized to 100% of the maximal perceived level.
|
48 after Placebo and Pomegranate training sessions
|
Change in the acute oral temperature response from Placebo to Pomegranate supplementation
Time Frame: 3min after Placebo and Pomegranate training sessions
|
oral temperature was recorded with a calibrated digital clinical thermometer (Omron, Paris, France; accuracy: 0.05°C) inserted sublingually for at least 3 min with the subjects in a seated resting position
|
3min after Placebo and Pomegranate training sessions
|
Change in the acute Heart rate ( HR) response from Placebo to Pomegranate supplementation
Time Frame: 3min after Placebo and Pomegranate training sessions
|
heart rate (HR) was recorded using a heart rate monitor
|
3min after Placebo and Pomegranate training sessions
|
Change in the acute systolic arterial pressure (SAP) response from Placebo to Pomegranate supplementation
Time Frame: 3min after Placebo and Pomegranate training sessions
|
systolic arterial pressure (SAP) was recorded using a manual sphygmomanometer
|
3min after Placebo and Pomegranate training sessions
|
Baseline values of body mass
Time Frame: at baseline status
|
at baseline status
|
|
baseline values of height
Time Frame: at baseline status
|
at baseline status
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Achraf Ammar, Dr, Institute of sport and physical education of Sfax, Tunisia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ammar A, Trabelsi K, Bailey SJ, Turki M, Bragazzi NL, Boukhris O, El Abed K, Bouaziz M, Ayadi F, Driss T, Souissi N, Chtourou H, Hokelmann A. Effects of natural polyphenol-rich pomegranate juice supplementation on plasma ion and lipid profiles following resistance exercise: a placebo-controlled trial. Nutr Metab (Lond). 2020 Apr 16;17:31. doi: 10.1186/s12986-020-00451-1. eCollection 2020.
- Ammar A, MounaTurki, Trabelsi K, Bragazzi NL, Boukhris O, Bouaziz M, Ayadi F, El Abed K, Driss T, Souissi N, Chtourou H, Bailey SJ, Hoekelmann A. Effects of natural polyphenol-rich pomegranate juice on the acute and delayed response of Homocysteine and steroidal hormones following weightlifting exercises: a double-blind, placebo-controlled trial. J Int Soc Sports Nutr. 2020 Mar 6;17(1):15. doi: 10.1186/s12970-020-00345-w.
- Ammar A, Turki M, Chtourou H, Hammouda O, Trabelsi K, Kallel C, Abdelkarim O, Hoekelmann A, Bouaziz M, Ayadi F, Driss T, Souissi N. Pomegranate Supplementation Accelerates Recovery of Muscle Damage and Soreness and Inflammatory Markers after a Weightlifting Training Session. PLoS One. 2016 Oct 20;11(10):e0160305. doi: 10.1371/journal.pone.0160305. eCollection 2016.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
February 1, 2015
Study Completion (Actual)
February 1, 2015
Study Registration Dates
First Submitted
February 24, 2016
First Submitted That Met QC Criteria
March 2, 2016
First Posted (Estimate)
March 3, 2016
Study Record Updates
Last Update Posted (Estimate)
March 3, 2016
Last Update Submitted That Met QC Criteria
March 2, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 16-2015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Data will be shared with researchers outside the primary research group for reanalysis purpose.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Lancaster UniversityRecruiting
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Natural Pomegranate Juice
-
University of LeedsCompletedHyperglycaemiaUnited Kingdom
-
University of WashingtonCompletedInflammation | Cardiovascular Disease | End Stage Renal DiseaseUnited States
-
Hillel Yaffe Medical CenterUnknown
-
Brigham and Women's HospitalUniversity of California, Los Angeles; POM Wonderful LLCCompletedIntrauterine Growth RestrictionUnited States
-
National Research Council, SpainIMDEA Food; CEIP (primary school) Jara Carrillo (Alcantarilla, Murcia, Spain); IES (secondary school) Alcántara (Alcantarilla, Murcia, Spain)CompletedGenotype, Metabotype and Dietary HabitsSpain
-
University of California, Los AngelesCompletedSkin Photoaging, Inflammation and Skin Pathogenic BacteriaUnited States
-
Rambam Health Care CampusUnknownEndometriosis | PCOS | Male Factor Infertility | Advised Maternal Age
-
University of Colorado, DenverPOM Wonderful LLCCompletedType 2 Diabetes MellitusUnited States
-
University of California, Los AngelesTerminatedInflammation | ErythemaUnited States
-
University of California, Los AngelesCompletedCardiovascular Diseases